| Literature DB >> 10396434 |
Abstract
A wide variety of drugs are now available for the acute treatment of migraine attacks. Although the new triptans are expensive, clinical trials have shown them to be highly effective, and they are the treatment of choice for disabling attacks unresponsive to cheaper medication. This article discusses the different clinical circumstances in which each preparation may prove the most effective.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10396434 DOI: 10.12968/hosp.1999.60.4.1095
Source DB: PubMed Journal: Hosp Med ISSN: 1462-3935